FDA highlights record-breaking number of generic drug approvals in October

FDA

9 November 2018 - Today, the U.S. FDA is providing a summary of the generic drug approval actions for the month of October 2018 as part of its efforts to improve patient access to high-quality, lower cost, safe and effective medicines.

In October, the FDA approved 110 generic drugs and tentatively approved 18 generic drugs, for a total of 128 approval actions. 

This included 23 first generics for brands that lacked competition and 17 complex generics.

Read FDA press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , US , Generic medicine